Stonebridge Capital Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-60
| Closed | -$15.4K | – | 278 |
|
|
2023
Q3 | $15.4K | Sell |
60
-29
| -33% | -$7.45K | ﹤0.01% | 535 |
|
|
2023
Q2 | $25.4K | Buy |
89
+29
| +48% | +$8.26K | ﹤0.01% | 472 |
|
|
2023
Q1 | $16.7K | Sell |
60
-10
| -14% | -$2.78K | ﹤0.01% | 535 |
|
|
2022
Q4 | $19.4K | Hold |
70
| – | – | ﹤0.01% | 498 |
|
|
2022
Q3 | $19K | Hold |
70
| – | – | ﹤0.01% | 475 |
|
|
2022
Q2 | $14K | Hold |
70
| – | – | ﹤0.01% | 538 |
|
|
2022
Q1 | $15K | Sell |
70
-2
| -3% | -$429 | ﹤0.01% | 582 |
|
|
2021
Q4 | $17K | Sell |
72
-12
| -14% | -$2.83K | ﹤0.01% | 532 |
|
|
2021
Q3 | $24K | Sell |
84
-70
| -45% | -$20K | ﹤0.01% | 455 |
|
|
2021
Q2 | $49K | Buy |
154
+84
| +120% | +$26.7K | ﹤0.01% | 471 |
|
|
2021
Q1 | $20K | Buy |
+70
| New | +$20K | ﹤0.01% | 500 |
|
|
2020
Q3 | – | Sell |
-10
| Closed | -$3K | – | 238 |
|
|
2020
Q2 | $3K | Hold |
10
| – | – | ﹤0.01% | 608 |
|
|
2020
Q1 | $3K | Hold |
10
| – | – | ﹤0.01% | 595 |
|
|
2019
Q4 | $3K | Hold |
10
| – | – | ﹤0.01% | 692 |
|
|
2019
Q3 | $2K | Hold |
10
| – | – | ﹤0.01% | 708 |
|
|
2019
Q2 | $2K | Buy |
+10
| New | +$2K | ﹤0.01% | 759 |
|